文献速递心脏核医学肿瘤 PET/CT

非酒精性脂肪肝伴心肌FDG摄取降低与冠状动脉粥样硬化相关

Non-alcoholic fatty liver disease with reduced myocardial FDG uptake is associated with coronary atherosclerosis.
PubMed 文献 · J Nucl Cardiol · 2019-05-10

本研究回顾性纳入418例连续接受18F-FDG PET/CT与冠状动脉CT血管造影(CCTA)的受试者,用心肌最大FDG值与肝脏平均标准化摄取值之比(SUVratio)评估心肌葡萄糖摄取,并以无增强CT评估脂肪肝。结果显示NAFLD患者低SUVratio比例显著更高(45.00% vs 19.82%,P < .001),低SUVratio独立关联NAFLD、非钙化斑块与显著狭窄。

要点

  • NAFLD患者低SUVratio比例显著高于无NAFLD者(45.00% vs 19.82%,P < .001)
  • 心肌FDG摄取与肝脏脂肪变呈显著负相关趋势(P < .001)
  • 低SUVratio独立关联NAFLD、非钙化斑块和显著狭窄

核心结论

  • NAFLD患者中心肌葡萄糖摄取降低与CCTA上的非钙化斑块及显著狭窄独立相关,提示冠状动脉粥样硬化及未来心血管事件风险增加。

研究设计与样本

  • 回顾性研究,连续纳入418例接受18F-FDG PET/CT与CCTA检查的受试者,用无增强CT评估脂肪肝。
  • 以心肌最大FDG值与肝脏平均SUV之比(SUVratio)估计心肌葡萄糖摄取,采用多变量logistic回归分析关联。

主要发现

  • NAFLD患者低SUVratio比例为45.00%,无NAFLD者为19.82%(P < .001)。
  • 关联趋势分析显示心肌FDG摄取与肝脏脂肪变呈显著负相关(P < .001)。
  • 按SUVratio四分位分层,低四分位(Q1和Q2)较高四分位(Q3和Q4)非钙化斑块比例更高(P = .003),趋势分析呈反向关系(P = .001)。
  • 多变量回归分析显示低SUVratio在调整临床重要因素后独立关联NAFLD、非钙化斑块和显著狭窄。

关键数值与推荐

  • 低SUVratio定义为心肌最大FDG值与肝脏平均SUV之比处于较低水平,原文以四分位分层表述(Q1和Q2 vs Q3和Q4)。
  • 非钙化斑块比例比较:Q1和Q2 vs Q3和Q4,P = .003;趋势分析P = .001。

临床怎么用

  • 对NAFLD患者行18F-FDG PET/CT时,可关注心肌FDG摄取(SUVratio)降低这一影像标志,提示需评估冠状动脉粥样硬化风险。
  • SUVratio降低独立关联非钙化斑块与显著狭窄,可作为心血管风险分层的补充信息,但需结合CCTA等检查综合判断。

局限性

  • 本文为回顾性研究,摘要未报告样本选择偏倚控制、随访结局及多中心验证等信息,结论的外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) has a significant role in the development of coronary atherosclerosis, independent of traditional cardiovascular and metabolic risk factors. However, the role of myocardial glucose uptake in NAFLD patients who develop coronary atherosclerosis was unclear. The aim of the present study thus was to investigate the association between NAFLD with characteristic of coronary atherosclerotic plaque and myocardial glucose uptake measured by using 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET). METHODS AND RESULTS: A total of 418 consecutive subjects who had undergone FDG PET/computed tomography (CT) and coronary computed tomography angiography (CCTA) were retrospectively investigated. Fatty liver was assessed by unenhanced CT. Coronary atherosclerotic plaques and stenosis on CCTA were evaluated. The metabolic parameters were measured on PET images. The ratio of the maximum myocardium FDG value to the mean standardized uptake value of liver (SUVratio) was calculated to estimate myocardial glucose uptake. The association of myocardial glucose uptake with NAFLD and coronary atherosclerosis was determined by multivariate logistic regression analysis. The proportion of low SUVratio in patients with NAFLD was significantly higher compared to those without NAFLD (45.00% vs 19.82%, P < .001). There was a significantly negative correlation between myocardial FDG uptake and hepatic steatosis in association trend analysis (P < .001). When the proportion of individuals with non-calcified plaque on CCTA is stratified by quartiles of SUVratio, patients with low quartiles of SUVratio were more likely to have higher proportion of non-calcified plaque than those with high quartiles of SUVratio (Q1 and Q2 vs Q3 and Q4, P = .003). The trend analysis presented correlated inversely relationship between non-calcified plaque and myocardial SUVratio (P = .001). Moreover, multivariate regression analysis showed that the low SUVratio was independently associated with NAFLD, non-calcified plaque, and significant stenosis after adjusting for clinically important factors. CONCLUSION: We demonstrated that the presence of reduced myocardial glucose uptake in patients with NAFLD was independently associated with non-calcified plaque and significant stenosis, suggesting an increased risk of coronary atherosclerosis and future cardiovascular events.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Tang K, Lin J, Ji X, et al. Non-alcoholic fatty liver disease with reduced myocardial FDG uptake is associated with coronary atherosclerosis. J Nucl Cardiol. 2019. PMID: 31077075. doi:10.1007/s12350-019-01736-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。